What is Eli Lilly & Co.'s Market Cap?

Eli Lilly & Co.'s Market Cap is $1.1T, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s Enterprise Value?

Eli Lilly & Co.'s Enterprise Value is $1.1T, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s Trailing P/E?

Eli Lilly & Co.'s Trailing P/E is 39.6×, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s Price / Sales?

Eli Lilly & Co.'s Price / Sales is 13.3×, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s EV / Revenue?

Eli Lilly & Co.'s EV / Revenue is 13.9×, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s EV / EBITDA?

Eli Lilly & Co.'s EV / EBITDA is 30.8×, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s Revenue (TTM)?

Eli Lilly & Co.'s Revenue (TTM) is $79.7B, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s Net Income (TTM)?

Eli Lilly & Co.'s Net Income (TTM) is $26.7B, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s EBITDA?

Eli Lilly & Co.'s EBITDA is $36.6B, based on as-reported figures from SEC (XBRL) filings.

What is Eli Lilly & Co.'s Diluted EPS (TTM)?

Eli Lilly & Co.'s Diluted EPS (TTM) is 28.37, based on as-reported figures from SEC (XBRL) filings.

Eli Lilly & Co. (LLY) Financial Statements

Eli Lilly & Co.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S5STL8

XNYS · usd

1,123.91▼ 25.45 (-2.21%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1,149.36

Day's Range1,113.55 – 1,134.53

52-Week Range712.05 – 1,292.65

Volume2.3M

Avg Volume2.6M

Share Statistics

Shares Outstanding

Employees50.0K

ExchangeXNYS

Listed1970-07-09

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Eli Lilly & Co. (LLY)

What is Eli Lilly & Co.'s Market Cap?: Eli Lilly & Co.'s Market Cap is $1.1T, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s Enterprise Value?: Eli Lilly & Co.'s Enterprise Value is $1.1T, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s Trailing P/E?: Eli Lilly & Co.'s Trailing P/E is 39.6×, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s Price / Sales?: Eli Lilly & Co.'s Price / Sales is 13.3×, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s EV / Revenue?: Eli Lilly & Co.'s EV / Revenue is 13.9×, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s EV / EBITDA?: Eli Lilly & Co.'s EV / EBITDA is 30.8×, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s Revenue (TTM)?: Eli Lilly & Co.'s Revenue (TTM) is $79.7B, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s Net Income (TTM)?: Eli Lilly & Co.'s Net Income (TTM) is $26.7B, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s EBITDA?: Eli Lilly & Co.'s EBITDA is $36.6B, based on as-reported figures from SEC (XBRL) filings.
What is Eli Lilly & Co.'s Diluted EPS (TTM)?: Eli Lilly & Co.'s Diluted EPS (TTM) is 28.37, based on as-reported figures from SEC (XBRL) filings.